Comparison of acupuncture pretreatment followed by letrozole versus letrozole alone on live birth in anovulatory infertile women with polycystic ovary syndrome: a study protocol for a randomised controlled trial
- PMID: 27855085
- PMCID: PMC5073597
- DOI: 10.1136/bmjopen-2015-010955
Comparison of acupuncture pretreatment followed by letrozole versus letrozole alone on live birth in anovulatory infertile women with polycystic ovary syndrome: a study protocol for a randomised controlled trial
Erratum in
-
Correction: Comparison of acupuncture pretreatment followed by letrozole versus letrozole alone on live birth in anovulatory infertile women with polycystic ovary syndrome: a study protocol for a randomised controlled trial.BMJ Open. 2017 Jun 15;7(6):e010955corr1. doi: 10.1136/bmjopen-2015-010955corr1. BMJ Open. 2017. PMID: 28619785 Free PMC article. No abstract available.
Abstract
Introduction: The high prevalence of insulin resistance in women with polycystic ovary syndrome (PCOS) is considered to be one of the major pathophysiological changes in PCOS that leads to anovulatory infertility. We hypothesise that electroacupuncture pretreatment improves insulin sensitivity and leads to a higher ovulation rate and greater chances of live birth after the induction of ovulation. The effect of electroacupuncture pretreatment followed by ovulation induction in women with anovulatory PCOS has not been investigated before, and we present here a randomised controlled trial to test this hypothesis by comparing electroacupuncture pretreatment followed by letrozole versus letrozole alone in anovulatory women with PCOS.
Methods/analysis: This is a multicentre, randomised,and controlled trial. A total of 384 patients will be enrolled in this study and will be randomly allocated by a central randomisation system to the treatment group or the control group in a 1:1 ratio. The treatment group will undergo 16 weeks of electroacupuncture pretreatment followed by 4 cycles of letrozole, and the control group will only undergo 4 cycles of letrozole. The primary outcome will be the live birth rate. All statistical analyses will be performed using the SPSS program V.21.0 (SPSS, Chicago, Illinois, USA), and a p value <0.05 will be considered statistically significant.
Ethics/dissemination: This study has been approved by the ethics committees of each participating centre. Written consent will be obtained from each patient and her husband before any study procedure is performed. Adverse events will be categorised, and the percentage of patients experiencing adverse events or serious adverse events during the treatment period will be documented. The results of this trial will be disseminated in peer-reviewed journals and presented at international meetings.
Trial registration number: NCT02491320.
Keywords: acupuncture pretreatment; letrozole; live birth rate; polycystic ovary syndrome.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Qiao J. [The diagnosis and treatment for amenorrhea in polycystic ovary syndrome]. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi 2008;24:902–4.
-
- Lin SQ, He FF, Chen ZJ et al. . [Clinical progress of gynecological endocrinology]. Edition 1. Beijing: Tsinghua Tongfang CD-ROM electronic publishing house 2013:106–9.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical